Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Mauro Orlando"'
Autor:
Martin Angel, Tomas Soule, Federico Losco, Mauro Orlando, Fernando Losada Lopez, Mora Amat, Martina Musumeci, Mariano López Suárez, Laura Lapuchescky, Joaquin Chemi, Jorge Jaunarena, Juan Camean, Roberto Bachur, Silvina Racioppi, Matias Chacon, Gustavo Villoldo, Juan Pablo Sade
Publikováno v:
Société Internationale d’Urologie Journal, Vol 4, Iss 6, Pp 454-457 (2023)
Inequity in cancer care access among LATAM countries is huge. Experience with gastrointestinal tumors in Latin America has shown care disparities can be reduced by equalizing access to high-quality medical knowledge in a context of a multidisciplinar
Externí odkaz:
https://doaj.org/article/0633af051ff549b2a40e5362f716ffbd
Publikováno v:
Journal of Cancer Research and Practice, Vol 5, Iss 2, Pp 43-46 (2018)
Advanced gastric and gastroesophageal junction cancers remain a major cause of concern considering their high incidence in Taiwan, poor outcomes essentially due to diagnosis at the advanced stage, and poor prognosis. These evidences along with the he
Externí odkaz:
https://doaj.org/article/a0c13e7eeb234800a1a3e814d8787326
Autor:
Chia-Jui Yen, Kei Muro, Tae-Won Kim, Masatoshi Kudo, Jin-Yuan Shih, Keun-Wook Lee, Yee Chao, Sang-We Kim, Kentaro Yamazaki, JooHyuk Sohn, Rebecca Cheng, Yawei Zhang, Polina Binder, Gu Mi, Mauro Orlando, Hyun Cheol Chung
Publikováno v:
Journal of Global Oncology, Vol 4, Pp 1-12 (2018)
Purpose: Several ramucirumab trials have reported a higher incidence of selected adverse events (AEs) in East Asian (EA) patients with cancer versus non-EA patients. A meta-analysis was conducted across six completed phase III trials to establish the
Externí odkaz:
https://doaj.org/article/f71b1c7f75fe4919a3bb26820389bf56
Autor:
Khelen Baraklou, Mauro Orlando, Sergey Orlov, Narayan Rayan, Piter Deyvi, Yana Kanivets, Baoguang Khan, Alan Brnabik
Publikováno v:
Современная онкология, Vol 14, Iss 1, Pp 32-40 (2012)
Externí odkaz:
https://doaj.org/article/cd5465649ed84a62b8a0adbdd6c9ab2d
Publikováno v:
Gynecologic Oncology Reports, Vol 10, Iss C, Pp 36-37 (2014)
Externí odkaz:
https://doaj.org/article/02a3d6052081442d98fcdf6dd44c93f4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Martín Zarbá, Federico Losco, Silvina Racioppi, Martina Musumeci, Mauro Orlando, Martín Ángel, Juan Pablo Sade, Matías Chacón
Publikováno v:
Oncología Clínica. 27
El PET/TC-PSMA es una técnica de imagen no invasiva que demostró ser más sensible y específica comparado con el PET-Colina, sobre todo con valores de PSA
Autor:
Kazuhiko Nakagawa, Ying Cheng, Tarun Puri, Mauro Orlando, Jianxing He, Tuan Stevon Nguyen, Joo Hang Kim, Sotaro Enatsu, Haruyasu Murakami, Pan-Chyr Yang, Rebecca R. Hozak, James Chih-Hsin Yang, Wan Li Zhang, Jin Hyoung Kang
Publikováno v:
Journal of Thoracic Oncology. 15:91-100
Introduction Clinical studies have shown that a combination of a tyrosine kinase inhibitor (TKI) and pemetrexed overcame acquired resistance to epidermal growth factor receptor (EGFR) TKI in NSCLC. Previously, pemetrexed+gefintib (P+G) had improved p
Autor:
Mauro Orlando Meurer Oliveira, Jorge Yoshinori Shida, André Mattar, Felipe Andreotta Cavagna, Luiz Henrique Gebrim
Publikováno v:
Mastology.
Introduction: Clinical staging (CS) has great importance for therapeutic programming and prognostic evaluation in patients diagnosed with breast cancer. Malignant breast tumors can be classified according to their immunohistochemical (IHC) profile. T
Autor:
Luiz Henrique Gebrim, Jorge Yoshinori Shida, Mauro Orlando Meurer Oliveira, Felipe Cavagna, Catharine Coelho da Silva Santos
Publikováno v:
Mastology. 30
Globally, breast carcinoma is the most commonly diagnosed cancer and the main cause of death by cancer among women. Its treatment requires a multidisciplinary approach, involving radiotherapists, oncologists and surgeons. Despite the advancements in